Neuropathological classification of Huntington's disease
- PMID: 2932539
- DOI: 10.1097/00005072-198511000-00003
Neuropathological classification of Huntington's disease
Abstract
In postmortem brain specimens from 163 clinically diagnosed cases of Huntington's disease (HD) the striatum exhibited marked variation in the severity of neuropathological involvement. A system for grading this severity was established by macroscopic and microscopic criteria, resulting in five grades (0-4) designated in ascending order of severity. The grade correlates closely with the extent of clinical disability as assessed by a rating scale. In five cases of clinically diagnosed HD there were no discernible neuropathological abnormalities (grade 0), suggesting that the anatomical changes lag behind the development of clinical abnormalities. In eight cases, neuropathological changes could only be recognized microscopically (grade 1). The earliest changes were seen in the medial paraventricular portions of the caudate nucleus (CN), in the tail of the CN, and in the dorsal part of the putamen. Counts of neurons in the CN reveal that 50% are lost in grade 1 and that 95% are lost in grade 4; astrocytes are greatly increased in grades 2-4. These studies indicate that analyses of the CN in grade 4 would reflect mainly its astrocytic composition with a component of remote neurons projecting to the striatum. Because of the relative preservation of the lateral half of the head of the CN in grades 1-2, these regions would reflect early cellular and biochemical changes in HD.
Similar articles
-
The selective vulnerability of striatopallidal neurons.Prog Neurobiol. 1999 Dec;59(6):691-719. doi: 10.1016/s0301-0082(99)00019-2. Prog Neurobiol. 1999. PMID: 10845758 Review.
-
The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.Neuroscience. 2000;97(3):505-19. doi: 10.1016/s0306-4522(00)00008-7. Neuroscience. 2000. PMID: 10828533
-
The neuropathological features of neuroacanthocytosis.Mov Disord. 1994 May;9(3):297-304. doi: 10.1002/mds.870090303. Mov Disord. 1994. PMID: 8041370 Review.
-
Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease.Neuroscience. 1993 Mar;53(1):159-68. doi: 10.1016/0306-4522(93)90294-p. Neuroscience. 1993. PMID: 7682296
-
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.J Neuropathol Exp Neurol. 1991 Nov;50(6):729-42. doi: 10.1097/00005072-199111000-00005. J Neuropathol Exp Neurol. 1991. PMID: 1836225
Cited by
-
Generation of Rhesus Macaque Embryos with Expanded CAG Trinucleotide Repeats in the Huntingtin Gene.Cells. 2024 May 13;13(10):829. doi: 10.3390/cells13100829. Cells. 2024. PMID: 38786052 Free PMC article.
-
TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.Sci Adv. 2024 May 17;10(20):eadl2036. doi: 10.1126/sciadv.adl2036. Epub 2024 May 17. Sci Adv. 2024. PMID: 38758800 Free PMC article.
-
HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.Cell Death Dis. 2024 May 14;15(5):337. doi: 10.1038/s41419-024-06716-4. Cell Death Dis. 2024. PMID: 38744826 Free PMC article.
-
Postmortem neuropathology in early Huntington disease.J Neuropathol Exp Neurol. 2024 Apr 19;83(5):294-306. doi: 10.1093/jnen/nlae022. J Neuropathol Exp Neurol. 2024. PMID: 38553027 Free PMC article.
-
Neuropathogenesis-on-chips for neurodegenerative diseases.Nat Commun. 2024 Mar 12;15(1):2219. doi: 10.1038/s41467-024-46554-8. Nat Commun. 2024. PMID: 38472255 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical